Clinical trials
Sleep Deprivation trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Direction Centrale du Service de Santé des Armées | 2 |
| Federal University of São Paulo | 2 |
| Hadassah Medical Organization | 2 |
| National Institute on Aging (NIA) | 2 |
| Uppsala University | 2 |
| Aretaieion University Hospital | 1 |
| Associação Fundo de Incentivo à Pesquisa | 1 |
| Auburn University | 1 |
| China Medical University, China | 1 |
| Eskisehir Osmangazi University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Deprivation | 39 |
| Chronobiology Disorders | 2 |
| Critical Illness | 2 |
| Epilepsy | 2 |
| Insulin Resistance | 2 |
| Metabolic Syndrome | 2 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Acute Coronary Syndrome | 1 |
| Alzheimer Disease | 1 |
| Anxiety Disorders | 1 |
Trials
Showing 76 to 39 of 39. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.